Senate Concurrent ResolutionChaptered/Signed
SCR 148: GM1 Gangliosidosis Awareness Day.
What SCR 148 does, verified June 25, 2026
This bill would declare May 23, 2026, as GM1 gangliosidosis awareness day in California. The purpose of this awareness day is to educate the public about this rare genetic disorder, which affects the nervous system. By declaring this day, the bill aims to raise awareness and support for individuals and families affected by GM1 gangliosidosis.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: Chaptered by Secretary of State. Res. Chapter 76, Statutes of 2026. (2026-05-21)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions11 total · showing 5
| May. 29, 2026 | Chaptered by Secretary of State. Res. Chapter 76, Statutes of 2026. |
| May. 29, 2026 | Enrolled and filed with the Secretary of State at 3 p.m. |
| May. 21, 2026 | Read. Adopted. (Ayes 68. Noes 0. Page 5232.) Ordered to the Senate. |
| May. 21, 2026 | In Senate. Ordered to engrossing and enrolling. |
| May. 21, 2026 | Read. Adopted. Ordered to the Senate. |
Latest bill textChaptered version, May 29, 2026 · 223 words
Senate Concurrent Resolution No. 148
CHAPTER 76
Relative to GM1 Gangliosidosis Awareness Day.
[ Filed with Secretary of State May 29, 2026. ]
LEGISLATIVE COUNSEL'S DIGEST
SCR 148, Padilla. GM1 Gangliosidosis Awareness Day.
This measure would declare May 23, 2026, as GM1 Gangliosidosis Awareness Day in California.
WHEREAS, GM1 Gangliosidosis is a rare inherited disease that results in neurodegeneration and a progressive loss of abilities until death, leaving children, adolescents, and adults impaired with significant physical and developmental disabilities; and
WHEREAS, GM1 Gangliosidosis is severely underdiagnosed and misdiagnosed and occurs in only one in every 100,000 to 200,000 live births; and
WHEREAS, Lack of public awareness and visibility of GM1 Gangliosidosis contributes to underdiagnosis and difficulties in accessing specialized services and proper rehabilitation and support; and
WHEREAS, Early diagnosis of GM1 Gangliosidosis is important to ensure timely management of clinical complications, genetic counseling, and, when available, treatment and therapeutic remedies; and
WHEREAS, The goal is to raise awareness and increase the accurate and timely diagnosis of this rare inherited lysosomal disorder known as GM1 Gangliosidosis; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature declares May 23, 2026, as GM1 Gangliosidosis Awareness Day in California; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
Text of SCR 148 as chaptered, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions